Liquid Biopsy Products
Products & Services
Information
Expedite the clinical implementation and standardization of next-generation sequencing (NGS)-based liquid biopsy assays with patient-like ctDNA reference samples featuring broad coverage of clinically relevant genomic alterations. Trust the industry-leading portfolio of Seraseq® circulating tumor DNA (ctDNA) reference materials to support the analytical validation and clinical deployment of your cell free DNA NGS-based assays.
Find out more about these products at https://www.seracare.com/liquid-biopsy.
